The Illinois General Assembly recently enacted changes to the Illinois Controlled Substances Act that will require prescribers to advise and inform patients about the addiction potential of opioids, and to also offer a prescription for an opioid antagonist (e.g., naloxone). This comes on the heels of an earlier law that requires pharmacists to offer the dispensing of an opioid antagonist with every opioid prescription. 

This activity is intended to change prescribers' interactions with patients for whom they are writing an opioid prescription. This activity will provide a summary of an update to current law that requires prescribers to advise such patients as to the addictive nature of opioids and the potential risk and harm that may occur as a result of opioid use. Participants will also be informed about a new requirement for prescribing an opioid to a patient: The prescriber must make the patient aware of opioid antagonist medications and offer to prescribe them. Finally, participants will be advised of the necessity of documenting in the patient's medical record that a conversation or communication on these two topics had occurred during the patient encounter in which an opioid was prescribed.

Learning Objectives:

1. Discuss the changes included in PA 102-1040 which amends the Illinois Controlled Substance Act and Pharmacy Practice Act.
2. Describe factors associated with an increased risk of overdose in patients receiving an appropriate prescription for an opioid analgesic
3. Identify appropriate naloxone route, dose, and dosing frequency when writing a prescription.

About the Presenter:

Brianna M. McQuade, PharmD, BCACP, MHPE has years of clinical and research experience. After graduating pharmacy school, she completed two years of pharmacy practice residency and a two-year academic research fellowship. She has expertise in health professions education, having completed her Masters in Health Professions Education in 2020. Her current role is a Clinical Assistant Professor at the University of Illinois at Chicago College of Pharmacy, and a clinical pharmacist at Mile Square Health Center, a Federally Qualified Health Center that serves the Chicago and Rockford, IL areas. She specializes in complex pharmacotherapy for underserved populations, focusing on substance use disorders and mental health. She practices in an interdisciplinary team that focuses on improving access to and quality of medication assisted recovery (MAR). As a member of the MAR team, she provides pharmacotherapy and medical education to trainees, other health professionals, and patients using non-stigmatizing language and approaches. She has evaluated implicit bias among healthcare team members and is published on the topic.

Who Can Attend:

Registration is limited to ISMS members and their employed staff. All others must pay $150 to attend. To pay, please email hpresearch@isms.org for instructions.

Accreditation

The Illinois State Medical Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

The Illinois State Medical Society designates this live activity for a maximum of 1 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure:

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.

This course will provide information about the diagnosis, treatment, and care of individuals with Alzheimer's disease and other dementias. Early diagnosis and thoughtful treatment and management strategies in patients suffering from Alzheimer’s and other dementias are important for maximizing quality of life for patients with these conditions. Furthermore, early detection may allow for treatment and management strategies that may help slow the progression of the disease. All physicians who may potentially engage with patients who are at risk for developing dementia should be up to date on the latest tools to aid in the diagnosis, treatment and management of these conditions.

Learning Objectives:

1. Describe assessment tools that can be used to help in the diagnosis of Alzheimer’s disease and other dementias
2. Identify and apply effective communication strategies for working with patients
3. Describe options and strategies for effective management and care planning for patients

About the Presenter:

Chad Yucus, MD is an expert in memory disorders and dementia, focusing on Alzheimer’s disease and other dementias. He earned his medical degree from the University of Illinois College of Medicine, and he completed residency and fellowship at the University of Iowa Hospitals & Clinics. Dr. Yucus is board certified in Behavioral Neurology & Neuropsychiatry, Clinical Neurophysiology, and Neurology.

Who Can Attend:

Registration is limited to ISMS members and their employed staff. All others must pay $150 to attend. To pay, please email hpresearch@isms.org for instructions.

Accreditation

The Illinois State Medical Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

The Illinois State Medical Society designates this live activity for a maximum of 1 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure:

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.